CDLR
Cadeler A/S
$23.40
-1.68%
$2.0B
No data for this timeframe.
Vol
Market Cap$2.0B
Cap SizeMid Cap
Inst. Holders2 funds
Inst. Value$118.0K
Inst. Activity0 buys / 2 sells
SEC Reports7
Exchange NYSE·Sector Deep Sea Foreign Transportation of Freight·Inc. G7·CIK 0001978867·Prev Close $23.80
Recent Activity
Jun 5, 2026
SEC
Cadeler A/S completed a small share buy-back programme on May 27, 2026, repurchasing 105,275 shares at an average price
6-K — Impact 2/10
May 27, 2026
SEC
Cadeler A/S announced a share buy-back programme of up to NOK 7.6 million (approx. EUR 700,000) to repurchase up to 105,
6-K — Impact 2/10
Mar 31, 2026
SEC
Cadeler A/S disclosed that BW Altor Pte. Ltd., closely associated with Chairman Andreas Sohmen-Pao, increased its stake
6-K — Impact 7/10
Inst.
MORGAN STANLEY — TRIM
6,131 shares ($114.0K)
Inst.
BANK OF AMERICA CORP — NEAR_EXIT
217 shares ($4.0K)
Price Targets
Historical data — last covering-analyst action Jun 2024. No current recommendation available.
$34.00 (Jun 2024)
Current $22.89
Low $34.00
Median $34.00
High $34.00
1 analysts
$34.00
$34.00
Analyst Ratings
6Strong Buy
6Buy
5Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 24, 2024 | Stifel | MAINTAIN | Buy → Buy |
| Jan 4, 2024 | Stifel | INITIATE | Buy |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $114.0K | TRIM |
| BANK OF AMERICA CORP | $4.0K | NEAR_EXIT |
2 institutional holders with $118.0K total value (6,348 shares) as of 2025-Q4. Top holders: MORGAN, BANK. Net selling activity: 2 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 6,131 | $114.0K | 96.6% | TRIM -45.7% |
| 2 | BANK OF AMERICA CORP /DE/ | 217 | $4.0K | 3.4% | NEAR_EXIT -94.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 11,296 | 6,131 | -45.7% | $114.0K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 3,963 | 217 | -94.5% | $4.0K | 2025-Q4 |
| MORGAN STANLEY | ADD | 6,809 | 11,296 | +65.9% | $233.3K | 2025-Q3 |
| UBS Group AG | DOUBLED | 963 | 5,480 | +469.1% | $113.2K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 32 | 3,366 | +10418.8% | $66.9K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 6,192 | 963 | -84.4% | $19.1K | 2025-Q2 |
| UBS Group AG | DOUBLED | 659 | 6,192 | +839.6% | $121.7K | 2025-Q1 |
| UBS Group AG | NEW | — | 659 | — | $14.7K | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
7 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 6 neutral. Avg impact: 4.1/10.
NEUTRAL
6-K
2/10
Cadeler A/S completed a small share buy-back programme on May 27, 2026, repurchasing 105,275 shares
Jun 5, 2026
NEUTRAL
6-K
2/10
Cadeler A/S announced a share buy-back programme of up to NOK 7.6 million (approx. EUR 700,000) to r
May 27, 2026
BULLISH
6-K
7/10
Cadeler A/S disclosed that BW Altor Pte. Ltd., closely associated with Chairman Andreas Sohmen-Pao,
Mar 31, 2026
NEUTRAL
6-K
4/10
Cadeler A/S announced that the Scorpio group increased its stake in the company through a subscripti
Mar 30, 2026
NEUTRAL
6-K
4/10
Cadeler A/S announced a temporary change in BW Altor's shareholding due to a share lending arrangeme
Mar 30, 2026
NEUTRAL
6-K
5/10
Cadeler A/S disclosed that BW Altor Pte. Ltd., a closely associated person of Chairman Andreas Sohme
Mar 30, 2026
NEUTRAL
6-K
5/10
Cadeler raised approximately EUR 175 million through a private placement to fund initial commitments
Mar 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jun 2024): 71% buy across 17 analysts — 6 strong buy, 6 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jun 2024. No current recommendation available.
$34.00 mean target (Jun 2024)
$34.00 Low
$34.00 High
| Metric | Value |
|---|---|
| Current Price | $22.89 |
| Target Low | $34.00 |
| Target Mean | $34.00 |
| Target Median | $34.00 |
| Target High | $34.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 3.4% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 68.7% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | 43.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.2B | 37.2% | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 24, 2024 | Stifel | MAINTAIN | Buy | Buy |
| Jan 4, 2024 | Stifel | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 6 | 5 | 0 | 0 | 71% | |
| May 1, 2026 | 6 | 6 | 5 | 0 | 0 | 71% | |
| Apr 1, 2026 | 6 | 6 | 5 | 0 | 0 | 71% | |
| Mar 1, 2026 | 8 | 6 | 4 | 0 | 0 | 78% | |
| Feb 1, 2026 | 8 | 6 | 4 | 0 | 0 | 78% | |
| Jan 1, 2026 | 8 | 6 | 4 | 0 | 0 | 78% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.